Hepatic alveolar echinococcosis has a high incidence in remote pastoral areas due to underdeveloped economy and low medical level, and the survival time of most patients is significantly reduced due to late detection and delayed treatment (
6). At present, the expression profile of circular RNA (circRNA) in the cyst wall of cystic echinococcosis has been studied by microarray sequencing (
10). However, there are few studies on RNA-seq for AE. In this study, RNA-seq will be used to further study the tissue expression profile of HAE, which is expected to provide certain ideas for the disease progression, treatment, and prognosis of HAE.
We analyzed RNA-seq data and found that many DEGs were mainly up-regulated. Gene ontology analysis mainly concentrated on immune-inflammatory related biological functional pathways, such as the up-regulated gene HLA-DRA enrichment process in the immune system, and TIMP1 enriched the signaling pathway mediated by inflammatory factors. Chemokines such as CCL18 are enriched into the biological functional pathways of immune response, indicating that hydatid infection causes differential changes in the expression of a large number of immune genes, which is consistent with literature reports (
11). However, some studies have shown that immune evasion may promote the progression of echinococcosis, so abnormal expression of immune factors such as TIMP1 and CCL18 enriched in the immune system may promote the progression of echinococcosis, but more experiments are needed to verify this result.
DEGs screened in this study overlapped with the currently known RBPs (
12), and 26 RBPs were found to be differentially expressed. Some studies have found that some RBPs are expressed in the liver and are related to liver metabolism or diseases. For example, RBP gene ELAVL1 can trigger autophagy activation, promote the degradation of autophagy ferritin, and eventually lead to iron-dependent iron death, which is expected to become a potential target for liver fibrosis treatment (
13). RNA-binding protein gene zinc finger protein 36 (ZFP36) may be a potential target for the treatment of liver fibrosis (
14). RNA-binding protein gene heteroribonucleoprotein L (HNRNPL) affects AKT signaling and DNA damage sensing in HCC (
15). Expression of RNA-binding protein RBMS3 is up-regulated in hepatic stellate cells (HSCs) and activation of fibrotic liver. By binding to Prx1 mRNA, RBMS3 controls the expression of Prx1 and indirectly synthesizes collagen α1, thus playing a role in the activation of hepatic stellate cell fibrosis (
16). In the progression of HAE, different degrees of liver fibrosis will appear in the liver tissues around the lesion. These fibrotic "shells" will affect the entry of drugs into the lesion tissues, thus reducing the efficacy of drugs, which is also an important reason for the infiltration and growth of the lesion tissues. Some of the 26 RBPs genes may play a role in promoting or inhibiting liver fibrosis in HAE, and the two genes participate in the progression of hepatic echinococcosis in a relatively dynamic equilibrium state. Therefore, the in-depth study of these genes will provide important clues for the treatment of HAE and the prevention of disease progression.
We also paid attention to the genes with significant changes in the level of AS, and enriched the positive regulation of protein dephosphorylation and other biological processes in GO analysis. Some studies have found that there are currently many studies targeting protein kinases as drug targets in the treatment of echinococcosis (
17), which is consistent with the research on the positive regulation of biological functional pathways of protein dephosphorylation in this study. We found that the AS gene MRPL24 was enriched in mitochondrial translation and ribosomal-related pathways in GO analysis and KEGG enrichment analysis. It has been reported that mitochondrial ribosomal drugs can be used as targets for the treatment of
Echinococcus multilocularis infection (
18). Therefore, we speculate that further research on the AS gene MRPL24 may provide more extensive ideas and methods for the treatment of HAE.
In this study, we screened out three credible ASEs: LTBP3, AP1B1, and ECHDC2. Studies have found that LTBP3, as a heparin-binding cytokine, plays an important role in carcinogenesis and tumor progression, and LTBP3 overexpression is a marker of poor prognosis in patients with primary HCC (
19). AP1B1 is related to the prognosis of HCC (
20), and patients with HBV-related HCC with high ECHDC2 expression can maintain relatively good hepatocyte metabolism and function, which may have a protective effect (
21). The above three genes have not been studied in HAE, and further research on these three genes may provide a favorable basis for the treatment and disease prognosis of HAE. Gene coexpression analysis is widely used to infer gene modules associated with diseases and other clinical traits (
22).
We also screened out four co-expressed RBP genes: S100A4, CD44, VIM, and LGALS3. Studies have found that S100A4 mediates the recruitment of macrophages at inflammatory sites in vivo (
23); S100A4 promotes liver fibrosis by activating HSCs (
24); the combination of CCR2 and CD44 promotes the recruitment of inflammatory cells in the process of fatty liver formation (
25); blocking the CD44-hyaluronic acid interaction reduces neutrophil adhesion in endotoxemic mice (
26). Vimentin is the most important gene for predicting advanced liver fibrosis (
27). The expression levels of Wnt3a, β-catenin, N-cadherin, Col1a1, α-SMA, VIM, CTGF, and TGF-β were observed to increase in the tissues near human AE lesions and in the Wnt3A-treated mouse group. On the contrary, the expression of E-cadherin is relatively low (
28). Galectin-3 encoded by LGALS3 belongs to the glycans binding protein family and can regulate basic cellular functions such as proliferation, migration, differentiation, apoptosis, and inflammation (
29). We identified five RBP-AS relationship pairs by co-expression: S100A4-ECHDC2; CD44-AP1B1; VIM-AP1B1; CD44-LTBP3; LGALS3-LTBP3. Combined with the above studies, we speculate that S100A4, CD44, VIM, and LGALS3 may participate in the regulation of AS of ECHDC2, AP1B1, and LTBP3 by binding RNA function, thus promoting the progression of hepatic hydatid disease. However, we have not conducted any research on whether there is regulation or not, and it is only speculation based on theory. There are certain limitations.
Data quality control and preprocessing are often the first step in processing next-generation sequencing (NGS) data of tumors. Not only can it help us evaluate the quality of sequencing data, but it can also help us obtain high-quality data for downstream data analysis (
30).
Immune chemokines have been studied in many diseases, like the cytokine IL-15, which could predict the prognosis of ESLD patients (
31). The mutual microbiota-host interaction through the purinergic P2X7 receptor (P2X7R) and secretory immunoglobulin A (
32). Therefore, we collected lesion tissue and liver tissue from 10 patients and conducted further studies on immune chemokines GNB3, CCL22, and RAC2.
GNB3 polymorphisms are linked to fibrotic responses in chronic liver diseases. In hepatic echinococcosis, cyst growth triggers fibrotic encapsulation, suggesting GNB3 may influence disease progression. Studies in other parasitic infections (e.g., schistosomiasis) highlight GNB3 variants as modifiers of host-pathogen interactions. No direct studies in echinococcosis yet.
CCL22 overexpression attracts Tregs to infection sites, suppressing anti-parasitic immunity. In HCV, CCL22 facilitates viral persistence — a parallel mechanism likely in Echinococcus infections. Preclinical studies suggest blocking CCL22/CCR4 axis enhances parasite clearance. No clinical trials for echinococcosis, but trials in cancer immunotherapy (e.g., anti-CCL22 antibodies) provide proof-of-concept.
RAC2 mutations impair macrophage chemotaxis and parasite engulfment. In hepatic echinococcosis, defective RAC2 signaling may explain poor cyst containment. RAC2 mediates oxidative burst in neutrophils — critical for killing Echinococcus larvae. Low ROS levels correlate with chronic infection. The above conclusion can provide guidance for the surgical resection range of HAE and be studied as potential targets.
Of course, we acknowledge that co-expression analysis and prediction of ASEs may have limitations or false positive results. However, in this study, we have taken active measures to reduce their impact on the results, such as quality control and statistical correction. Alternative splicing some articles have mentioned, the distribution of actual low-quality bases in the sequence may lead to many short sequences and may reduce the accuracy of downstream alignment, increasing the sequencing depth of some reference sites (
30). Therefore, data preprocessing is becoming increasingly important in data analysis.
5.1. Conclusions
In summary, the differentially expressed mRNA, differentially expressed variable splicing genes, and RBPs may participate in the occurrence and development of liver alveolar hydatid disease, and play an important role in the invasion and metastasis of alveolar hydatid lesions. GNB3, CCL22, and RAC2 genes are highly expressed within the lesion and significantly lowly expressed in the liver tissue 1 cm away from the lesion. The above conclusion can provide guidance for the surgical resection range of HAE and be studied as potential targets. In the later stage, we will increase the sample size and further detect the expression levels of GNB3, CCL22, RAC2, RBPs, AS, etc., genes in peripheral blood to provide more powerful theoretical support for potential targets.